−2.25 B KRW
333.95 M KRW
3.56 M
About FEMTOBIOMED
Sector
Industry
CEO
Sang-Hyeon Lee
Website
Headquarters
Seongnam-si
Founded
2011
ISIN
KR7327610002
FIGI
BBG00PN9BN51
Femtobiomed, Inc. engages in the development of pharmaceutical products. Its services include intracellular delivery for cell therapy. The company was founded on July 8, 2011 and is headquartered in Seongnam-si, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 327610 is 5,780 KRW — it has increased by 2.85% in the past 24 hours. Watch FEMTOBIOMED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange FEMTOBIOMED stocks are traded under the ticker 327610.
327610 stock has risen by 15.60% compared to the previous week, the month change is a 5.09% rise, over the last year FEMTOBIOMED has showed a 2.85% increase.
327610 reached its all-time high on Aug 4, 2021 with the price of 24,900 KRW, and its all-time low was 4,510 KRW and was reached on Dec 17, 2024. View more price dynamics on 327610 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
327610 stock is 15.80% volatile and has beta coefficient of 1.52. Track FEMTOBIOMED stock price on the chart and check out the list of the most volatile stocks — is FEMTOBIOMED there?
Today FEMTOBIOMED has the market capitalization of 48.79 B, it has increased by 8.08% over the last week.
Yes, you can track FEMTOBIOMED financials in yearly and quarterly reports right on TradingView.
No, 327610 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 12.00 employees. See our rating of the largest employees — is FEMTOBIOMED on this list?
Like other stocks, 327610 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FEMTOBIOMED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FEMTOBIOMED technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FEMTOBIOMED stock shows the strong sell signal. See more of FEMTOBIOMED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.